Carregant...
Economic Evaluation of Add-on Levetiracetam for the Treatment of Refractory Partial Epilepsy in Korea
OBJECTIVE: This study estimated the expected cost-effectiveness ratio expressed as the incremental cost per seizure-free day (SFD) gained and the incremental cost per quality adjusted life year (QALY) gained when using levetiracetam (LEV) as add-on therapy from a third-party payer perspective. METHO...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Korean Neuropsychiatric Association
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2796067/ https://ncbi.nlm.nih.gov/pubmed/20046394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4306/pi.2009.6.3.185 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|